Interest of the association azacitidine-lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype. - Scherman, E; Malak, S; Perot, C; Gorin, N C; Rubio, M T; Isnard, F (Leukemia (08876924), 2012)